Genevant Sciences

Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industrys most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. We leverage our world-class delivery systems and related technologies to bring new medicines to patients who need them. We do this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows us to maintain our leadership position in the space. Best-in-class LNP + next generation ligand conjugate technologies First and only FDA-approved siRNA-LNP utilizes Genevant technology Nucleic acid payload design expertise Several...

Rna,rare disease,drug development,biologics,rnai,mrna,ind,research,lnp delivery,drug delivery,formulations,lnp,lipid nanoparticles,sirna,gene editing,ligand conjugates,oligonucleotides,extrahepatic,and liver disease

Genevant sciences operates in the Biotechnology industry.

Genevant sciences's revenue is 11m - 100m

Genevant sciences has 11 - 50 employees.